CUNEO, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 1.092
AS - Asia 1.013
EU - Europa 574
SA - Sud America 53
AF - Africa 49
Continente sconosciuto - Info sul continente non disponibili 46
OC - Oceania 1
Totale 2.828
Nazione #
US - Stati Uniti d'America 1.073
SG - Singapore 318
VN - Vietnam 270
CN - Cina 232
GB - Regno Unito 135
IT - Italia 101
SE - Svezia 85
HK - Hong Kong 61
DE - Germania 56
IN - India 41
FR - Francia 40
NL - Olanda 39
BR - Brasile 37
IE - Irlanda 32
RU - Federazione Russa 27
JP - Giappone 23
BD - Bangladesh 16
TG - Togo 15
ZA - Sudafrica 15
EE - Estonia 12
CA - Canada 11
PH - Filippine 11
AR - Argentina 10
CH - Svizzera 9
CI - Costa d'Avorio 7
UA - Ucraina 7
JO - Giordania 6
BG - Bulgaria 5
FI - Finlandia 5
QA - Qatar 5
EC - Ecuador 4
ES - Italia 4
GR - Grecia 4
KR - Corea 4
TH - Thailandia 4
TN - Tunisia 4
TW - Taiwan 4
AT - Austria 3
IQ - Iraq 3
MX - Messico 3
AE - Emirati Arabi Uniti 2
BE - Belgio 2
EG - Egitto 2
HN - Honduras 2
ID - Indonesia 2
IR - Iran 2
MA - Marocco 2
NG - Nigeria 2
PK - Pakistan 2
RS - Serbia 2
TR - Turchia 2
UZ - Uzbekistan 2
AL - Albania 1
AU - Australia 1
CL - Cile 1
CO - Colombia 1
CZ - Repubblica Ceca 1
HR - Croazia 1
JM - Giamaica 1
LB - Libano 1
LT - Lituania 1
NP - Nepal 1
PL - Polonia 1
PR - Porto Rico 1
PT - Portogallo 1
SA - Arabia Saudita 1
SC - Seychelles 1
SN - Senegal 1
SV - El Salvador 1
Totale 2.782
Città #
Singapore 190
Southend 122
Ashburn 111
Santa Clara 98
San Jose 83
Fairfield 76
Chandler 63
Ho Chi Minh City 62
Beijing 59
Hong Kong 58
Hanoi 52
Houston 45
Seattle 41
Los Angeles 34
Dong Ket 32
Dublin 32
Woodbridge 32
Wilmington 28
Boardman 27
Cambridge 27
Ann Arbor 25
Princeton 24
New York 18
Tokyo 16
Lauterbourg 15
Lomé 15
Bologna 14
Nanjing 13
Westminster 13
Bremen 12
Buffalo 12
Padova 12
Council Bluffs 9
Da Nang 8
Rome 8
Turin 8
Abidjan 7
Guangzhou 7
Jinan 7
Saint Petersburg 7
Shenyang 7
Amman 6
Berlin 6
Chicago 6
Frankfurt am Main 6
Haiphong 6
Wuhan 6
Biên Hòa 5
Doha 5
Florence 5
Hebei 5
Medford 5
Milan 5
Norwalk 5
Rimini 5
San Diego 5
São Paulo 5
Zhengzhou 5
Bern 4
Hyderabad 4
London 4
Nanchang 4
Shenzhen 4
Sofia 4
Tianjin 4
Toronto 4
Athens 3
Atlanta 3
Baghdad 3
Bangkok 3
Brooklyn 3
Chennai 3
Dallas 3
Hefei 3
Helsinki 3
Hải Dương 3
Johannesburg 3
Long Xuyen 3
Redondo Beach 3
Redwood City 3
Shanghai 3
Torino 3
Vellore 3
Vĩnh Long 3
Abeokuta 2
Andover 2
Belo Horizonte 2
Bhopal 2
Brussels 2
Bühl 2
Changsha 2
Charlotte 2
Falls Church 2
Grand Rapids 2
Inglewood 2
Langfang 2
Lanzhou 2
Latina 2
Madrid 2
Manila 2
Totale 1.738
Nome #
Baseline factors associated with response to ruxolitinib: an independent study on 408 patients with myelofibrosis 216
Complex chromosomal rearrangements leading to MECOM overexpression are recurrent in myeloid malignancies with various 3q abnormalities 213
First Report of the Gimema LAL1811 Phase II Prospective Study of the Combination of Steroids with Ponatinib As Frontline Therapy of Elderly or Unfit Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia 211
Efficacy and safety of ruxolitinib in intermediate-1 IPSS risk myelofibrosis patients: Results from an independent study 208
The emerging role of GSK-3β in the pathobiology of classical Hodgkin lymphoma 180
HIGH RATE OF COMPLETE HEMATOLOGICAL RESPONSE IN ELDERLY PH+ ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PATIENTS BY INNOVATIVE SEQUENTIAL USE OF NILOTINIB AND IMATINIB: A GIMEMA CLINICAL TRIAL LAL 1408 159
Treating Ph+ Acute Lymphoblastic Leukemia (ALL) in the Elderly: The Sequence of Two Tyrosine Kinase Inhibitors (TKI) (Nilotinib and Imatinib) Does Not Prevent Mutations and Relapse. 157
Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia 148
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 143
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients. 142
Extremely high rate of complete hematological response of elderly Ph+ acute lymphoblastic leukemia (ALL) patients by innovative sequential use of Nilotinib and Imatinib. A GIMEMA Protocol LAL 1408 141
Sequential use of first and second generation TKIs are effective on prolonged overall survival in elderly population affected by Ph+ acute lymphoblastic leukemia: the GIMEMA experience 129
Expression of the immunoglobulin superfamily cell membrane adhesion molecule Cd146 in acute leukemia 73
Isolamento e caratterizzazione immunofenotipica di cellule non-emopoietiche presenti in versamenti ascitici e pleurici di pazienti con malattie ematologiche 65
GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia 64
Aberrant expression of HLA-DR antigen by bone marrow-derived mesenchymal stromal cells from patients affected by acute lymphoproliferative disorders 63
Individual quality assessment of autografting by probability estimation for clinical endpoints: a prospective validation study from the European group for blood and marrow transplantation 62
Cytogenetic and molecular cytogenetic profile of bone marrow-derived mesenchymal stromal cells in chronic and acute lymphoproliferative disorders 57
Cellule staminali circolanti in pazienti con infarto miocardico 55
Cellule staminali circolanti in pazienti con infarto miocardico 54
Cytogenetic aspects of B- cell chronic lymphocytic leukemia: their correlation with clinical stage and different polyclonal mitogens 50
CXCR4 pos circulating progenitor cells coexpressing monocytic and endothelial markers correlating with fibrotic clinical features are present in the peripheral blood of patients affected by systemic sclerosis 48
Studio dei progenitori emopoietici circolanti in pazienti con infarto del miocardio 42
Alpha interferon in T helper phenotype chronic lymphocytic leukemia: a report of three cases 41
Studio dei progenitori emopoietici e delle cellule endoteliali in cors di patologie autoimmuni: ruolo della citometria a flusso multicolore 40
Total loss of p53 DNA sequences in acute myeloid leukemia 35
Preferential expression of the transcription coactivator HTIF1alpha gene in acute myeloid leukemia and MDS-related AML 32
Totale 2.828
Categoria #
all - tutte 8.706
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.706


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022220 0 15 12 24 21 13 4 15 12 16 50 38
2022/2023306 21 36 14 40 17 22 7 28 57 38 18 8
2023/202496 1 21 14 12 13 13 7 2 5 5 2 1
2024/2025485 19 72 39 39 116 17 33 6 23 47 9 65
2025/20261.015 82 88 79 39 144 51 73 43 275 90 25 26
2026/202751 17 34 0 0 0 0 0 0 0 0 0 0
Totale 2.828